Table 1 The top nine affected drugs with the description
Rank | Drug name | Description | Antiplatelet |
|---|---|---|---|
1 | Clopidogrel | A prodrug of a platelet inhibitor used to reduce the risk of myocardial infarction and stroke68. | √ |
2 | Idarubicin | An anthracycline antineoplastic agent, showing activity against leukemias69. | × |
3 | Vinorelbine | An anti-mitotic chemotherapy drug, used in the treatment of malignancies. Its side effects relate to antiplatelet70. | √ |
4 | Ticlopidine | A platelet aggregation inhibitor used in the prevention of conditions associated with thrombi71. | √ |
5 | Tamoxifen | A non-steroidal antiestrogen, with direct inhibition of platelet activation for cardiovascular effects72. | √ |
6 | Danazol | A synthetic steroid, having a certain effect on immune thrombocytopenic purpura (ITP)73. | √ |
7 | Mipomersen | An oligonucleotide drug for hypercholesterolemia, associating with clinically insignificant platelet declines74. | √ |
8 | Chloroquine | An aminoquinolone derivative for systemic lupus erythematosus by regulating antiplatelet effect, and lipid75. | √ |
9 | Quinine | An alkaloid derived from the bark of the cinchona tree related to antiplatelet76. | √ |
